Huiyao Gu
Qingchun Road 79
Hangzhou, China
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
FAPα+ Macrophages Orchestrate Immune Evasion in Multiple Myeloma by Dual Regulation of PD-L1 and T Cell Senescence.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 07, 2025
Macrophages promote aberrant DNA repair in multiple myeloma via the CXCL5/8-CXCR2 axis.
Journal: Haematologica
Published: January 07, 2025
Calcium silicate/bortezomib combinatory therapy for multiple myeloma.
Journal: Journal of materials chemistry. B
Published: February 06, 2023
Interleukin-32γ promotes macrophage-mediated chemoresistance by inducing CSF1-dependent M2 macrophage polarization in multiple myeloma.
Journal: Cancer immunology, immunotherapy : CII
Published: January 15, 2022
RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-κB and MAPK signaling pathways.
Journal: Oncogene
Published: July 30, 2021
Metabolic reprogramming in macrophage responses.
Journal: Biomarker research
Published: September 26, 2020
Emerging agents and regimens for multiple myeloma.
Journal: Journal of hematology & oncology
Published: August 01, 2020
Dihydroartemisinin Modulates Apoptosis and Autophagy in Multiple Myeloma through the P38/MAPK and Wnt/β-Catenin Signaling Pathways.
Journal: Oxidative medicine and cellular longevity
Published: January 14, 2020
The NEDD4-1 E3 ubiquitin ligase: A potential molecular target for bortezomib sensitivity in multiple myeloma.
Journal: International journal of cancer
Published: March 05, 2019
Therapeutic effects of the novel subtype-selective histone deacetylase inhibitor chidamide on myeloma-associated bone disease.
Journal: Haematologica
Published: November 08, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026